179 related articles for article (PubMed ID: 24274056)
21. Competition potency of siRNA is specified by the 5'-half sequence of the guide strand.
Yoo JW; Kim S; Lee DK
Biochem Biophys Res Commun; 2008 Feb; 367(1):78-83. PubMed ID: 18164261
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and silencing properties of siRNAs possessing lipophilic groups at their 3'-termini.
Ueno Y; Kawada K; Shibata A; Yoshikawa K; Wataya Y; Kitade Y
Nucleic Acids Symp Ser (Oxf); 2008; (52):503-4. PubMed ID: 18776474
[TBL] [Abstract][Full Text] [Related]
23. The design, preparation, and evaluation of asymmetric small interfering RNA for specific gene silencing in mammalian cells.
Chang C; Hong SW; Dua P; Kim S; Lee DK
Methods Mol Biol; 2013; 942():135-52. PubMed ID: 23027049
[TBL] [Abstract][Full Text] [Related]
24. Principles of Dicer substrate (D-siRNA) design and function.
Amarzguioui M; Rossi JJ
Methods Mol Biol; 2008; 442():3-10. PubMed ID: 18369774
[TBL] [Abstract][Full Text] [Related]
25. Short interfering RNA strand selection is independent of dsRNA processing polarity during RNAi in Drosophila.
Preall JB; He Z; Gorra JM; Sontheimer EJ
Curr Biol; 2006 Mar; 16(5):530-5. PubMed ID: 16527750
[TBL] [Abstract][Full Text] [Related]
26. Increased potency and longevity of gene silencing using validated Dicer substrates.
Hefner E; Clark K; Whitman C; Behlke MA; Rose SD; Peek AS; Rubio T
J Biomol Tech; 2008 Sep; 19(4):231-7. PubMed ID: 19137112
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and silencing properties of siRNAs possessing lipophilic groups at their 3'-termini.
Ueno Y; Kawada K; Naito T; Shibata A; Yoshikawa K; Kim HS; Wataya Y; Kitade Y
Bioorg Med Chem; 2008 Aug; 16(16):7698-704. PubMed ID: 18644731
[TBL] [Abstract][Full Text] [Related]
28. Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy.
Kim DH; Behlke MA; Rose SD; Chang MS; Choi S; Rossi JJ
Nat Biotechnol; 2005 Feb; 23(2):222-6. PubMed ID: 15619617
[TBL] [Abstract][Full Text] [Related]
29. Dicer-labile PEG conjugates for siRNA delivery.
Kow SC; McCarroll J; Valade D; Boyer C; Dwarte T; Davis TP; Kavallaris M; Bulmus V
Biomacromolecules; 2011 Dec; 12(12):4301-10. PubMed ID: 22053777
[TBL] [Abstract][Full Text] [Related]
30. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing.
Bartlett DW; Davis ME
Biotechnol Bioeng; 2007 Jul; 97(4):909-21. PubMed ID: 17154307
[TBL] [Abstract][Full Text] [Related]
31. Recombinant Dicer efficiently converts large dsRNAs into siRNAs suitable for gene silencing.
Myers JW; Jones JT; Meyer T; Ferrell JE
Nat Biotechnol; 2003 Mar; 21(3):324-8. PubMed ID: 12592410
[TBL] [Abstract][Full Text] [Related]
32. Human Dicer binds short single-strand and double-strand RNA with high affinity and interacts with different regions of the nucleic acids.
Lima WF; Murray H; Nichols JG; Wu H; Sun H; Prakash TP; Berdeja AR; Gaus HJ; Crooke ST
J Biol Chem; 2009 Jan; 284(4):2535-48. PubMed ID: 19017633
[TBL] [Abstract][Full Text] [Related]
33. Interaction of human T-cell lymphotropic virus type I Rex protein with Dicer suppresses RNAi silencing.
Abe M; Suzuki H; Nishitsuji H; Shida H; Takaku H
FEBS Lett; 2010 Oct; 584(20):4313-8. PubMed ID: 20869963
[TBL] [Abstract][Full Text] [Related]
34. Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference.
Ui-Tei K; Naito Y; Takahashi F; Haraguchi T; Ohki-Hamazaki H; Juni A; Ueda R; Saigo K
Nucleic Acids Res; 2004; 32(3):936-48. PubMed ID: 14769950
[TBL] [Abstract][Full Text] [Related]
35. Silencing activity of 2'-O-methyl modified anti-MDR1 siRNAs with mismatches in the central part of the duplexes.
Petrova NS; Meschaninova MI; Venyaminova AG; Zenkova MA; Vlassov VV; Chernolovskaya EL
FEBS Lett; 2011 Jul; 585(14):2352-6. PubMed ID: 21704032
[TBL] [Abstract][Full Text] [Related]
36. Expressing functional siRNAs in mammalian cells using convergent transcription.
Tran N; Cairns MJ; Dawes IW; Arndt GM
BMC Biotechnol; 2003 Nov; 3():21. PubMed ID: 14604435
[TBL] [Abstract][Full Text] [Related]
37. [Dicer efficiently converts large dsRNAs into siRNAs suitable for COX-2 gene].
Luo H; Hu DX; Chen P
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 32(3):437-42. PubMed ID: 17611321
[TBL] [Abstract][Full Text] [Related]
38. Enzymatically produced pools of canonical and Dicer-substrate siRNA molecules display comparable gene silencing and antiviral activities against herpes simplex virus.
Romanovskaya A; Paavilainen H; Nygårdas M; Bamford DH; Hukkanen V; Poranen MM
PLoS One; 2012; 7(11):e51019. PubMed ID: 23226452
[TBL] [Abstract][Full Text] [Related]
39. Suppression of RNA interference by adenovirus virus-associated RNA.
Andersson MG; Haasnoot PC; Xu N; Berenjian S; Berkhout B; Akusjärvi G
J Virol; 2005 Aug; 79(15):9556-65. PubMed ID: 16014917
[TBL] [Abstract][Full Text] [Related]
40. RNA interference with 2',4'-bridged nucleic acid analogues.
Abdur Rahman SM; Sato H; Tsuda N; Haitani S; Narukawa K; Imanishi T; Obika S
Bioorg Med Chem; 2010 May; 18(10):3474-80. PubMed ID: 20427190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
